Nephrogenic diabetes insipidus in a patient taking cidofovir [7]

Lancet

Volumn 350, Issue 9075, 1997, Pages 413-414

  Schliefer, Kirsten ^a   Rockstroh, Jürgen K ^b   Spengler, Ulrich ^b   Sauerbruch, Tilman ^b  

^a UNIVERSITY OF BONN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; COTRIMOXAZOLE; CREATININE; FOSCARNET; PROBENECID;

ADULT; CASE REPORT; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DIGESTIVE SYSTEM ULCER; DRUG HALF LIFE; DRUG METABOLISM; HUMAN; LETTER; MALE; NEPHROGENIC DIABETES INSIPIDUS; ORAL DRUG ADMINISTRATION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROTEINURIA; RETINITIS;

EID: 0030757295     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)64137-2     Document Type: Article

References (3)

1. Lea AP, Bryson HM. Cidofovir. Drugs 1996; 52: 225-30.
2. Lazesari JP, Stagg JR, Kuppermann BD, et al. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. Ann Intern Med 1997; 126: 257-63.
3. Ho HT, Woods KL, Bronson JJ, De Boeck H, Martin JC, Hitchcock MJM. Intracellular metabolism of antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine. Mol Pharmacol 1991; 41: 197-202.